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Abstract Adult rats exposed to methylazoxymethanol ace-
tate (MAM) at embryonic day 17 (E17) display robust patho-
logical alterations in the hippocampus. However, discrepan-
cies exist in the literature regarding the behavioural effects of
this pre-natal manipulation. Therefore, a systematic assess-
ment of MAM E17-induced behavioural alterations was con-
ducted using a battery of dorsal and ventral hippocampus-
dependent tests. Compared to saline controls, MAM E17-
treated rats displayed deficits in spatial reference memory in
both the aversive hidden platform watermaze task and an ap-
petitive Y-maze task. Deficits in the spatial reference memory
watermaze task were replicated across three different cohorts
and two laboratories. In contrast, there was little, or no, effect
on the non-spatial, visible platform watermaze task or an ap-
petitive, non-spatial, visual discrimination task, respectively.
MAM rats were also impaired in the spatial novelty preference
task which assesses short-term memory, and displayed re-
duced anxiety levels in the elevated plus maze task. Thus,
MAM E17 administration resulted in abnormal spatial infor-
mation processing and reduced anxiety in a number of
hippocampus-dependent behavioural tests, paralleling the ef-
fects of dorsal and ventral hippocampal lesions, respectively.
These findings corroborate recent pathological and physiolog-
ical studies, further highlighting the usefulness of MAM E17
as a model of hippocampal dysfunction in at least some as-
pects of schizophrenia.
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Introduction
Schizophrenia is a complex and heterogeneous disorder, asso-
ciated with profound deficits in a wide variety of cognitive
domains, including attention, memory and executive function
(Heinrichs and Zakzanis. 1998; Nuechterlein et al. 2004).
Structural and functional alterations in cortical and subcortical
areas are thought to mediate these deficits (Antonova et al.
2004; Reichenberg and Harvey. 2007). Evidence for the im-
portance of the hippocampus in the pathology of schizophre-
nia is compelling (for review, see Harrison. 2004; Tamminga
et al. 2010). Most of these findings derive from post-mortem,
brain imaging and neuropsychological studies, and range from
reduced hippocampal volume (Lawrie and Abukmeil. 1998;
Nelson et al. 1998; Wright et al. 2000; Honea et al. 2005),
abnormal neuronal organisation (Kovelman and Scheibel.
1984; Heckers and Konradi. 2002; Zhang and Reynolds.
2002) and altered synaptic transmission (Tsai et al. 1995;
Gao et al. 2000; Medoff et al. 2001; Harrison et al. 2003;
Schobel et al. 2009) to deficits in hippocampal-dependent
memory tasks and changes in task-related functional activa-
tion of the hippocampus (Heckers et al. 1998; Aleman et al.
1999; Weiss and Heckers. 2001; Cirillo and Seidman. 2003;
Jessen et al. 2003; Leube et al. 2003; Hanlon et al. 2006;
Ongur et al. 2006; Achim et al. 2007; Boyer et al. 2007;
Folley et al. 2010; Stone and Hsi. 2011).
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Evidence consistent with hippocampal alterations in
schizophrenia also comes from animal models, including not
only neonatal ventral hippocampal damage but also the em-
bryonic day 17 methylazoxymethanol acetate (MAM E17)
rodent model which exhibits robust hippocampal pathology.
Through selective disturbance of proliferation and migration
of neuronal precursor cells, MAM E17 treatment interferes
with the development of cortical and subcortical brain regions,
and results in a series of structural and functional alterations
that are consistent with those observed in schizophrenia
(Moore et al. 2006; Lodge and Grace. 2009). Changes in the
hippocampus include volume reduction, aberrant neuronal or-
ganisation and excitability, deficits in synaptic transmission
and synaptic plasticity, and abnormal neuronal oscillatory ac-
tivity (Gourevitch et al. 2004; Moore et al. 2006; Penschuck
et al. 2006; Lodge and Grace. 2007; Matricon et al. 2010;
Chin et al. 2011; Hradetzky et al. 2012; Phillips et al. 2012a,
b; Sanderson et al. 2012; Snyder et al. 2013). Alongside these
robust anatomical and physiological alterations, a number of
studies have looked at the effects of MAM E17 treatment in
behavioural paradigms assessing hippocampus-dependent
spatial memory (Gourevitch et al. 2004; Flagstad et al. 2005;
Le Pen et al. 2006; Featherstone et al. 2009; Hazane et al.
2009; Snyder et al. 2013). While there appear to be consistent,
robust and reliable spatial working/short-term memory defi-
cits in MAM E17 rats (Gourevitch et al. 2004; Featherstone
et al. 2009; Hazane et al. 2009), the picture for associative,
long-term spatial reference memory tasks is less clear cut.
Spatial reference memory has been assessed primarily
using the fixed location, hidden escape platform version of
the open-field Morris watermaze task but with mixed results.
For example, whereas one study demonstrated a clear impair-
ment inMAME17 rats during watermaze acquisition (Hazane
et al. 2009), another study found no impairment whatsoever
(Flagstad et al. 2005). In both studies, latencies and path
lengths were reported during acquisition, but there was no
explicit test of spatial memory abilities such as a probe test
in which the platform is removed from the pool and the rats
allowed to swim freely for a short-period of time to see where
they spend their time searching. It is important to point out that
animals can show sizeable improvements in performance dur-
ing watermaze training (i.e. reductions in latencies and/or path
lengths) without necessarily learning anything about the actu-
al allocentric spatial location of the platform (e.g. they can
simply learn to swim away from the side walls). Thus, an
explicit test of spatial memory is desirable. In a more recent
study, Snyder and colleagues (2013) did perform probe tests at
the end of watermaze training and found that although MAM
E17 animals were impaired during acquisition (in terms of
escape latencies) when tested at either juvenile (P12–P21) or
adolescent ages (P28–P45), a different picture emerged from
the probe tests. Although juvenile MAM E17 rats were im-
paired, MAM E17 rats were not impaired if tested as
adolescents. In addition, none of these aforementioned studies
have included a non-spatial, control task such as a visible
platform task to exclude the possibility that any watermaze
deficit could be due to disruption of sensorimotor or
motivational processes rather than a deficit in spatial
memory per se. Furthermore, all of these studies have
used the aversive watermaze task and the effects of
MAM E17 on a non-aversive, associative spatial refer-
ence memory task have not been examined. Thus, the
specificity and generality of any spatial reference mem-
ory deficit have not been assessed.
The rationale for the present study therefore was to re-
investigate MAM E17-induced behavioural alterations, using
a battery of hippocampus-dependent spatial memory tests,
assessing both short-term and long-term spatial memory, and
using both aversive and non-aversive testing paradigms.
Specifically, spatial memory performance was assessed using
the aversive open-field Morris watermaze spatial reference
memory task, the appetitive Y-maze spatial reference memory
test and the spontaneous Y-maze spatial novelty preference
test which assesses short-term memory. Appropriate hippo-
campus-independent, non-spatial control tests were also in-
cluded. While lesion studies have demonstrated an important
role for the dorsal hippocampus in spatial memory, the ventral
hippocampus has been more associated with anxiety
(Bannerman et al. 2002, 2003, 2004, 2014; Kjelstrup et al.
2002; McHugh et al. 2004; Fanselow and Dong. 2010).
Therefore, ventral hippocampal dysfunction was also assessed
using the elevated plus maze test of anxiety.
Materials and methods
Subjects
Time-mated Sprague-Dawley dams (Charles River, UK) were
dosed intraperitoneally at embryonic day 17 with 22 mg/kg of
methylazoxymethanol acetate (MAM) or 0.9 % saline (1 ml/
kg). At postnatal day 28, litters were weaned. Male offspring
were kept and housed with non-littermates from the same
treatment group, in standard housing conditions (two to four
rats per cage, light phase 0700–1900, controlled temperature
and humidity). Rats were 4–8 months old at the time of be-
havioural testing and had ad libitum access to food and water,
except prior to the appetitive Y-maze spatial reference mem-
ory and T-maze visual discrimination tasks, during which they
were maintained at 85 % of their free-feeding weight. All
experiments were conducted during the light phase, by an
experimenter unaware of the rats’ group assignments and in
accordance with the European Communities Council
Directive 86/609/EEC regarding the care and use of animals
for experimentation.
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Order of testing
A total of 57 saline and 63 MAM rats were used in the
present study. Experiments were performed across two
separate laboratories (University of Oxford, UK in col-
laboration with Eli Lilly, and Orion Pharma, Finland).
Two cohorts of animals were used in each laboratory.
Two cohorts of 24 and 8 animals per group, respective-
ly, were used by Orion Pharma in Finland to assess
MAM E17 effects in the Morris watermaze hidden plat-
form spatial reference memory test and their within-lab
reproducibility.
In addition, behavioural performance on this task and
other tests of spatial memory, non-spatial memory con-
trol tasks and a test of anxiety was also assessed in a
different laboratory (Oxford, UK). The first cohort of 12
saline and 15 MAM rats used by Eli Lilly/Oxford, UK
was tested in five different behavioural paradigms: the
fixed location, hidden platform, spatial reference memo-
ry Morris watermaze task, the elevated plus maze test of
anxiety, spontaneous spatial novelty preference in an
enclosed Perspex Y-maze (a test of short-term spatial
memory), appetitively motivated spatial reference mem-
ory in the elevated Y-maze, and non-spatial, visual dis-
crimination learning in an enclosed T-maze. The second
cohort of 13 saline and 16 MAM rats was used for the
assessment of anxiety levels in experimentally naïve an-
imals using the elevated plus maze, and was then tested
in the non-spatial visible platform Morris watermaze
task (see Table 1 for summary of behavioural experi-
ments performed by all the four separate cohorts of
MAM E17 rats).
Hidden platform spatial reference memory in the Morris
watermaze
Orion pharma protocol
Testing was conducted in a black circular tank of 1.5 m diam-
eter and containing clear water at a temperature of 21±1 °C.
Rats were trained for 5 days (three trials per day). The plat-
form was located at the centre of the NE quadrant of the pool.
During each trial, rats were placed into the pool facing the side
wall at one of three start locations (NW, SE and SW; chosen
randomly across trials) and allowed to swim until they found
the platform or for a maximum of 60 s. Any rat that failed to
find the platform within 60 s was guided to its location by the
experimenter and allowed to remain on the platform for 30 s.
The rat was left for another 30 s outside the pool in a cage
before commencing the next trial.
Eli Lilly/Oxford protocol
The protocol used at Oxford University was similar in many
respects to the one described above. However, there were
some important differences. Most notably, we included (i) a
probe (transfer) test to assess spatial memory performance
24 h after the last spatial training trial, and (ii) a non-spatial,
visible platform control task which was run in separate groups
of rats.
Animals had no swim pre-training before testing. Testing
was conducted in a large circular tank (diameter 2.0 m, depth
0.6 m) containing water at a temperature of 25±1 °C, and to a
depth of 0.3 m. To escape from the water, rats had to find a
hidden escape platform (diameter 10 cm, 1 cm below the
water surface) situated in a fixed spatial location. The water
was made opaque by the addition of 2 l of semi-skimmed
milk, which not only prevented the subjects from seeing the
platform but also allowed efficient tracking of swim paths.
The pool was surrounded by prominent distal extra-maze cues
that could be used as landmarks (shelves, racks of equipment,
posters on walls, etc.). Swim paths were tracked by a video
camera mounted in the ceiling, and relayed to a computer for
image analysis using specialised software (HVS Image
Analyse, Hampton, UK). The x and y coordinates of each rat’s
position were sampled in real time at 10 Hz by an Acorn
computer, using a software that provided measures such as
latency, path length and swim speed during acquisition, and
the time spent in each quadrant of the pool during the probe/
transfer tests. Rats were trained for 8 days (four trials per day).
The platform was located at the centre of either the NWor SE
quadrant of the pool. The number of rats trained to each plat-
form location was counterbalanced with respect to treatment
group. During each trial, rats were placed into the pool facing
the side wall at one of eight start locations (arbitrarily desig-
nated N, S, E, W, NE, NW, SE and SW; chosen randomly
Table 1 Summary of behavioural experiments for all four cohorts of
MAM 17 rats
Orion cohort 1 (n=24)
1. Spatial reference memory in the Morris watermaze
Orion cohort 2 (n=8)
1. Spatial reference memory in the Morris watermaze
Oxford cohort 1 (n=12–15):
1. Spatial reference memory in the Morris watermaze
2. Elevated plus maze
3. Spontaneous spatial novelty preference test in an enclosed Y-maze
4. Appetitive, spatial reference memory Y-maze task
5. Appetitive, non-spatial (visual discrimination) T-maze task
Oxford cohort 2 (n=13–16)
1. Elevated plus maze
2. Non-spatial (visible platform) version of the watermaze task
The table includes the total number of rats used per group per cohort as
well as the temporal sequence in which the different behavioural exper-
iments were performed
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across trials) and allowed to swim until they found the plat-
form or for a maximum of 90 s. Any rat that failed to find the
platform within 90 s was guided to its location by the exper-
imenter and allowed to remain on the platform for 30 s before
commencing the next trial. On completion of four daily trials,
rats were dried and then returned to their home cages.
Twenty-four hours after the fourth and eighth days of test-
ing, (i.e. after trials 16 and 32, respectively), probe/transfer
tests were conducted to determine the extent to which the rats
had learned about the location of the platform. The platform
was removed from the pool, and each rat was allowed to swim
freely for 60 s. The percentage of time spent, and the number
of (would-be) platform crossings, in each quadrant were re-
corded for each animal. In the analysis of the distribution of
time spent searching the four quadrants, the numerator term in
the degrees of freedom was reduced by one to control for the
fact that the four quadrant dwell times were not independent of
each other. In the analysis of the number of annulus
(platform) crossings in each quadrant, an accuracy score
was calculated as follows: number of crossings in the
goal platform annulus− (number of crossings in all 3
other would-be platform annuli /3).
Visible platform learning in the Morris watermaze
The visible platform task was performed at Oxford University
on a separate group of rats and used as a control for the hidden
platform task. This variant of the task involves similar senso-
rimotor and motivational demands but without the need for
spatial information processing. Rats were trained for 3 days
(four trials per day) to find a visible escape platform (diameter
10 cm, 1 cm above the water surface), which had a variable
spatial location. The escape location was indicated by place-
ment of a visible, black-and-white-striped cylinder directly
above the platform. The extra-maze spatial cues were not oc-
cluded during visible platform training. To ensure that there
was no spatial solution to the task, both the platform position
and the start location were varied randomly from trial to trial.
Spatial reference memory in the Y-maze
Appetitively motivated spatial reference memory was exam-
ined using a Y-maze made of black painted wood. It had a
central polygonal area 9 cm in diameter, to which three iden-
tical arms were attached (each 70×9×5 cm). A small metal
food well was glued to each arm 5 cm from the distal end. The
maze was elevated 70 cm above the floor on a central stand,
on which the entire maze could be rotated. The room
contained a variety of prominent features, which served as
distal spatial cues. Rats were familiarized to the maze in their
colony holding room (i.e. not the testing room), until they
were running freely on the maze and readily consuming pellet
rewards from the food wells.
For spatial memory testing, a goal arm (defined according
to its allocentric position relative to the room cues) was des-
ignated for each rat. Goal arms were counterbalanced with
respect to treatment group such that approximately equal num-
bers of saline and MAM animals were trained to each of the
three arms. The start arm for each trial was determined by
pseudorandom sequence (with equal numbers of starts from
each of the other two arms in any one session, and no more
than three consecutive starts from the same arm). The maze
was rotated 120° in a clockwise or anticlockwise direction at
random intervals during testing, to prevent the rat identifying
the rewarded arm by any olfactory, visual or tactile cues
unique to a particular arm. For each trial, the food well on
the goal arm was filled with a 45 mg sucrose pellet reward,
and the rat was placed at the distal end of a start arm, facing
outwards. A correct choice was scored when the rat entered
the goal arm directly. If the rat chose incorrectly, it was imme-
diately removed from the maze and then returned to its home
cage. Rats were trained for 6 days (10 trials per day) with an
inter-trial interval (ITI) of approximately 10 min. During the
final 10 trials, the pellet reward was delivered into the food
well Bonly^ after rats had made a choice (post-choice baiting).
This was to ensure that rats were unable to solve the task by
smelling the food reward.
Visual discrimination learning in the T-maze
The T-maze visual discrimination task was used as a control
for the appetitive Y-maze spatial reference memory task, in-
volving similar sensorimotor and motivational demands but
without the need for spatial information processing. The
enclosed, dark grey, wooden T-maze had a start arm and two
interchangeable goal arms; one painted grey arm and one
black and white striped arm (each 60×10×30 cm). An alu-
minium food well was attached 3 cm from the distal end of
each of these two arms. Rats were familiarized to the maze
with neutral/dark grey arms and then assigned to either one of
two goal arms (i.e. the arm which will be rewarded during the
task; grey vs. black/white stripes). Assignment to goal arms
was counterbalanced across treatment groups. The right/left
location of the rewarded goal arm varied from trial to trial
(i.e. there was no spatial solution), and was determined ac-
cording to a pseudorandom sequence (with equal numbers
of right/left presentation and no more than three consecutive
trials with the same correct location). For each trial, the food
well in the goal arm was filled with a 45 mg sucrose pellet
reward, and the rat was placed at the distal end of the start arm,
facing outwards. A correct choice was scored when the rat
entered the assigned/correct goal arm directly. If the rat chose
incorrectly, it was immediately removed from the maze and
then returned to its home cage. Rats were trained for 8 days
(10 trials per day) with an ITI of approximately 10 min.
During the final block of 10 trials, the pellet reward was
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delivered into the food well Bonly^ after rats had made a
choice (post-choice baiting). This was to ensure that rats were
unable to solve the task by smelling the food reward.
Spatial novelty preference in the Y-maze
MAM and saline rats were also tested on a spontaneous, spa-
tial novelty preference task to assess spatial short-term mem-
ory. This task provides a non-aversive, non-appetitive exper-
imental context in which behaviour is driven by animals’ nat-
ural exploratory drive. The Y-maze used was made of clear
plastic and had three identical arms (each 49×17×27 cm).
Rats were pseudo-randomly assigned two arms (the ‘start
arm’ and the ‘familiar arm’) to which they were exposed dur-
ing the first 5-min phase of the task (the ‘exposure phase’).
The entrance to the third ‘novel’ arm was closed off by the
presence of a large opaque Perspex block. At the end of the 5-
min period, the rat was removed from the maze, placed back
in its home cage for 1 min, following which the ‘test’ phase
started. The Perspex block was removed. Rats were placed
back into the start arm and allowed to explore the entire maze
(i.e. all 3 arms) for 2 min. Spatial novelty preference was
assessed twice, in different rooms and with different arm as-
signments each time. For each test, the amount of time spent in
each arm and the number of entries into each arm were record-
ed, during both the exposure and test phases. For the test
phase, both a difference score (time in novel arm−time in
familiar arm) and a discrimination ratio (time in novel arm/
(time in novel+familiar arms)) were calculated. Animals com-
monly display a marked preference for the novel arm during
the test phase.
Anxiety in the elevated plus maze
Anxiety levels of MAM and saline rats were assessed using
the elevated plus maze task. The maze consisted of two open
grey arms (each 61×10×3 cm) and two closed grey arms
(each 61×10×30 cm), and was arranged so that the two open
arms were opposite each other. The maze had a 10×10-cm
central square and was on a stand 39 cm above the ground.
Rats were placed individually into the centre of the maze,
facing into one of the open arms and were allowed to explore
the maze freely. Each testing session lasted for 5 min, during
which the number of entries and time spent in each open or
closed armwere measured. Rats were then removed and placed
back into their home cages. Testing was performed in the two
separate cohorts of rats. The first cohort (i.e. trained cohort)
previously underwent watermaze testing whereas the second
cohort did not undergo any behavioural testing before elevated
plus maze testing (i.e. experimentally naïve cohort). The dis-
crimination ratios of either time or entries into open vs. closed
arms were calculated for each group as follows: time or entries
into open arms/(time or entries into open+closed arms).
Statistical analyses
Behavioural data were analysed using repeatedmeasures anal-
ysis of variance (RM-ANOVA) followed by post hoc compar-
isons (i.e. Tukey’s test), where appropriate. The assumptions
required for parametric ANOVA were checked (normality,
equal variance) and data transformed where needed. In addi-
tion, one sample t tests were also used to determine whether
mean responses were significantly different from chance.
Results
Impaired aversive spatial reference memory in the watermaze
Orion pharma
MAM rats showed a profound and enduring impairment at
acquiring the hidden platform watermaze task, in both cohorts
of animals tested (Fig. 1a: cohort 1; Fig. 1b: cohort 2). Path
lengths were analysed using a two-way RM-ANOVA, with
treatment group as between-subject factor and trial block as a
within-subject factor. These analyses revealed a significant ef-
fect of treatment group [cohort 1: F(1,46)=72.47; p<0.001;
cohort 2:F(1,14)=65.57; p<0.001], a main effect of trial block
[cohort 1: F(4,184)=52.43; p<0.001; cohort 2: F(4,56)=
34.38; p<0.001], and a significant group×block interaction
[cohort 1: F(4,184)=3.76; p<0.01; cohort 2: F(4,56)=5.82;
p<0.001]. Importantly, performance on trial one of block one
of training was the same for both groups [path length (m);
cohort 1: saline: 11.23±1.1; MAM: 12.83±1.0; p>0.1; cohort
2, saline: 12.83±0.9; MAM: 12.68±2.1; p>0.1].
Eli Lilly/Oxford
The MAM E17 rats tested in Oxford also showed a profound
and enduring impairment at acquiring the hidden platform
watermaze task (Fig. 2a). Path lengths were analysed using a
two-way RM-ANOVA, with treatment group as a between-
subjects factor, and trial block as a within-subjects factor.
This analysis revealed a significant main effect of treatment
group [F(1,25)=41.25; p<0.001], a significant effect of block
[F(7,175)=30.58; p<0.001], but no group by block interaction
[p>0.1]. Inspection of Fig. 2a shows that theMAM-treated rats
were performing worse than the saline controls from the very
first block of testing. Importantly, however, a separate analysis
demonstrated that performance on trial one of block one of
training was the same for both groups [path length (m), saline:
25.7±2.2; MAM: 22.6±2.8; p>0.1]. Further analyses includ-
ing trial within block as a further within-subject factor revealed
a main effect of trial [F(3,600)=11.87; p<0.001], but no trial
by group or trial by group by block interaction [both p>0.1].
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Spatial memory for the platform location was also assessed
during two probe/transfer tests (conducted 24 h after trials 16
and 32), in which the escape platform was removed and the
rats swam freely for 60 s (Fig. 2b). Analyses comparing the
percentage of time spent in each quadrant by the two groups
during both transfer tests revealed a main effect of quadrant in
both probe tests [F(2,75)=15.03; p<0.001 in probe test 1;
F(2,69)=43.01; p<0.001 in probe test 2], a trend towards a
group by quadrant interaction in probe test 1 [F(2,75)=2; p=
0.07], and a significant group by quadrant interaction in probe
test 2 [F(2,75)=4; p<0.05 in test 2]. A separate analysis com-
paring the time spent in the training (goal) quadrant only re-
vealed that each group showed a consistent spatial preference
for the training quadrant when compared to chance perfor-
mance [saline vs. 25 % chance: p<0.001 in both tests;
MAM vs. 25 % chance: p<0.01 in test 1 and p<0.001 in test
2]. However, MAM-treated rats were significantly impaired
compared to saline controls in terms of time spent in the train-
ing quadrant [MAMvs. saline: p<0.01 in test 1 and p<0.05 in
test 2]. This deficit in spatial memory was confirmed by com-
parison of the accuracy score based on annulus crossings in
each of the probe/transfer tests [MAM vs. saline: p<0.05 in
test 1 and p<0.001 in test 2; saline vs. chance: p<0.05 in test 1
and p<0.001 in test 2; MAM vs. chance: p>0.05 in both
tests].
Impaired aversive visible platform learning in the watermaze
A separate cohort of watermaze naïve MAM and saline rats
was tested on the non-spatial visible platform version of the
Morris watermaze task (Fig. 2c). Interestingly, MAM rats
showed a small but significant impairment at acquiring this
task. A two-way RM-ANOVA conducted on path lengths re-
vealed a significant effect of block [F(2,54)=133.13;
p<0.001], a main effect of treatment group [F(1,27)=9.02;
p<0.01], and a trend towards group by block interaction
[F(2,54)=2.85; p=0.06]. Again, visual inspection of Fig. 2c
suggested that MAM rats were impaired during the first block
of watermaze testing, although important analysis of trial one
of block one of training revealed that performance was the
same for both groups [path length (m), saline: 19.2±1.5;
MAM: 23.2±1.5; p>0.05].
To determine whether the MAM rats were disproportion-
ately impaired on the spatial version of the task, a further
statistical analysis was conducted which compared path
lengths to the platform for the first three training blocks on
the respective tasks (spatial versus non-spatial, Oxford stud-
ies). Analysis of the two aversively motivated watermaze
studies together suggested that MAM rats were disproportion-
ately impaired in spatial learning compared to the visible plat-
form task. Indeed, there was a significant group by task inter-
action [F(1,52)=15.66; p<0.001]. However, it is important to
point out that the spatial and non-spatial (visible platform)
watermaze tasks were conducted with different cohorts of rats,
and were run as separate experiments, and so it is not strictly
appropriate to combine these datasets in a single ANOVA.
Therefore, caution is necessary when interpreting the results
of such a combined analysis.
Impaired appetitive spatial reference memory in the Y-maze
To examine whether the MAM deficit extended to a non-
aversively motivated, associative spatial memory task,
MAM and saline rats were tested in the appetitive Y-maze
spatial reference memory task (Fig. 3a). Consistent with the
watermaze results, appetitively motivated spatial memory was
also impaired in MAM rats. Percent correct choices were
analysed using a two-way RM-ANOVA, with treatment group
as a between-subject factor and trial block as a within-subject
factor. These analyses revealed a main effect of treatment
group [F(1,24)=5.14; p<0.05], a significant effect of trial
block [F(5,120)=44.29; p<0.001], but no group by block
interaction [p>0.1]. Post-choice reinforcement in block 6 con-
firmed that rats were not locating the food reward by virtue of
its odour.
Fig. 1 MAM E17 exposure impaired hidden platform spatial reference
memory in the Morris watermaze. Hidden platform Morris watermaze
spatial reference memory was assessed by Orion Pharma (Finland) in
two separate cohorts of rats: (a) cohort 1, n=24 per group; (b) cohort 2,
n=8 per group. Results are presented as the mean±SEM of the path
lengths travelled to reach the platform across each of the 3-trial training
blocks for both MAM E17 rats (grey) and saline controls (white). ***
P<0.001 vs. the saline-treated group
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Normal appetitive visual discrimination learning
in the T-maze
MAM rats were not impaired in the acquisition of an
appetitively motivated, non-spatial, visual discrimination
learning T-maze task (Fig. 3b). A two-way RM-ANOVAwith
treatment group as a between-subject factor and trial block as
a within-subject factor, revealed a significant effect of trial
block [F(7,168)=13.87; p<0.001] but no main effect
of treatment group or group by block interaction [both
p>0.1]. Again, post-choice reinforcement in block 8
confirmed that rats were not locating the food reward
by virtue of its odour.
To further investigate the specificity of MAM-induced spa-
tial deficits, another statistical analysis was conducted which
compared percent correct choices for the first 6 training blocks
on the respective spatial and non-spatial (Y- and T-maze)
tasks. Analysis of the two appetitively motivated maze studies
together revealed a significant group by task interaction [F(1,
48)=4.5; p<0.05]. Again, it is important to point out that the
spatial and non-spatial (visible platform) appetitive maze tasks
were conducted with different cohorts of rats, and were run as
separate experiments, and so it is not strictly appropriate to
combine these datasets in a single ANOVA. Again, we should
be cautious when interpreting the results of this combined
analysis.
Impaired spontaneous spatial novelty preference
in the Y-maze
MAM rats were impaired in spatial novelty preference com-
pared to saline-treated controls. The two tests were analysed
Fig. 2 MAM E17 exposure impaired both hidden (a–b) and visible
platform learning (c) in the aversively motivated Morris watermaze.
Hidden and visible platform Morris watermaze learning tasks were
assessed in a separate laboratory (Oxford University in collaboration
with Eli Lilly, UK) and in two separate cohorts of rats. a Results from
the hidden platform learning task are presented as the mean±SEM of the
path lengths travelled to reach the platform across each of the four-trial
training blocks for both MAM E17 rats (grey, n=15) and saline controls
(white, n=12). b Transfer tests were conducted 24 h after the fourth (TT1)
and eighth (TT2) block of training. Results are presented as the mean±
SEM of the percentage of time spent in the goal quadrant (G) and other
three quadrants, as well as the platform crossing accuracy score for each
transfer test.Dashed lines represent 25% chance level. cResults from the
visible platform learning task are presented as the mean±SEM of the path
lengths travelled to reach the platform across each of the four-trial training
blocks for MAME17 rats (grey, n=16) and saline controls (white, n=13).
*P<0.05; **P<0.01; ***P<0.001 vs. the saline-treated group. #P<0.05;
##P<0.01; ###P<0.001 vs. chance level
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together using three-way ANOVAswith test/room as a within-
subject factor, however, there was no main effect of test or
group by test interaction [both p>0.1]. Although both treat-
ment groups made a greater number of entries and spent more
time in the novel arm vs. the familiar arm during the test phase
(Fig. 4a–b), the mean time spent in the novel arm was signif-
icantly greater for saline controls [saline vs. MAM: p<0.05].
This was confirmed when comparing the difference scores
(but not the discrimination ratios) of the time spent in the
novel vs. familiar arm, respectively, against chance perfor-
mance and between treatment groups (Fig. 4c–d). Both
MAM and saline controls performed significantly above
chance [difference score: saline p<0.001 and MAM
p<0.001 vs. 0 s value; discrimination ratio: saline p<0.001
andMAM p<0.001 vs. 0.5 value], therefore suggesting robust
novelty preference in both treatment groups. However, MAM
rats spent a significantly shorter period of time exploring the
novel arm compared to saline controls, as illustrated by the
difference score [saline vs. MAM: p<0.05] but not the dis-
crimination ratio which did not quite reach statistical signifi-
cance [saline vs. MAM: p>0.1].
To investigate whether the difference in novelty preference
between groups was due to MAM animals spending less time
in the Bto-be-familiar arm^ during the exposure phase, these
times were compared between treatment groups (Fig. 4e).
Interestingly,MAM rats actually spent significantly more time
exploring the to-be familiar arm during the exposure phase
[saline vs. MAM: p<0.05]. Thus, the deficit was not due to
less exposure to the to-be familiar arm in the MAM group
during the exposure phase.
Reduced anxiety levels in the elevated plus maze
Compared to saline controls, MAM rats showed reduced
levels of anxiety as measured using the elevated plus maze
(Fig. 5). The two sets of results were analysed together using
ANOVAs with cohort (experimentally naïve versus
watermaze experienced) and treatment condition (saline ver-
sus MAM) as between-subject factors. MAM rats made more
entries and spent a higher proportion of time in the open arms
of the maze compared to saline controls. Both entries and time
open/closed arm ratios confirmed both a trend and a signifi-
cant effect of treatment group, respectively [entries ratio: F(1,
52)=2.9, p<0.1; time ratio: F(1,52)=6.1, p<0.05]. There was
also a main effect of cohort (experimentally naïve versus
watermaze experienced; [time ratio: F(1,52)=27.6, p<0.001;
entries ratio: F(1,52)=10.9, p<0.01]). Experimentally naive
rats spent a higher proportion of time in the closed arms and
made fewer entries into the open arms of the maze
compared to rats previously trained in the watermaze.
However, importantly there was no group by cohort
interaction [p>0.1], therefore suggesting that previous
watermaze experience may alter anxiety levels per se,
but did not influence the effect of MAM treatment on
anxiety levels on the elevated plus maze.
Discussion
The present data demonstrate thatMAME17 administration is
sufficient to induce deficits in performance on associative,
spatial reference memory tasks, both in the aversive hidden
platform watermaze task and in the appetitive Y-maze task. In
contrast, no or minor alterations were observed in the non-
spatial T-maze visual discrimination learning task and the vis-
ible platform watermaze task, respectively. MAM rats were
also impaired in the spatial novelty preference task which
assesses short-term memory and exhibited reduced anxiety
levels in the elevated plus maze. Overall, these findings are
noteworthy for their demonstration of MAM E17-induced al-
terations in a wide range of dorsal and ventral hippocampus-
dependent behavioural tests.
Fig. 3 MAM E17 exposure impaired spatial (a) but not visual
discrimination learning (b) in the appetitively motivated Y-maze and T-
maze, respectively. Results are presented as the mean±SEM of the
percentage of correct choices made by MAM E17 (grey, n=14) and
saline controls (white, n=12), across each of the 10-trial training blocks
during either the Y-maze spatial reference learning task (a) or the T-maze
visual discrimination learning task (b). Dashed lines represent 50 %
chance levels. *P<0.05 vs. the saline-treated group
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MAM E17 induced abnormal spatial processing
Despite strong evidence highlighting the anatomical and phys-
iological alterations observed in the hippocampus of MAM
E17 rats, discrepancies exist in the behavioural literature using
this model. The present findings corroborate previous studies
which have reported deficits in spatial working/short-term
memory in these animals (Gourevitch et al. 2004;
Featherstone et al. 2009; Hazane et al. 2009). We also demon-
strate a robust deficit in spatial reference memory performance
in MAME17 rats in theMorris watermaze task, a result which
though in agreement with one previous study (Hazane et al.
2009), is at odds with another (Flagstad et al. 2005).
The reason for such discrepancies remains unclear. It is
possible that strain differences could be important in determin-
ing the behavioural effects of MAM treatment on watermaze
performance. The study of Flagstad et al. (2005), which re-
ported no effect on watermaze acquisition in MAM E17 rats
was performed with Wistar rats, whereas all of the other stud-
ies discussed here, including our present study, have been
conducted in Sprague-Dawley rats. Another important factor
could be differences in the watermaze paradigms used in dif-
ferent laboratories. The different studies described here, in-
cluding our own study, have varied in a number of different
ways, including the size of the pool (ranging from anywhere
between 1 and 2 m in diameter), the training protocols used,
and in terms of the extra-maze spatial cues available to the
animals to solve the task. Indeed, it is very difficult, if not
impossible, to standardize the allocentric spatial cues that are
available to the animals in the watermaze task across different
laboratories. Nevertheless, it is possible to assess and demon-
strate the hippocampal dependency of a particular watermaze
task. In this respect, it is important to point out that we have
previously reported robust and reliable deficits with cytotoxic
hippocampal lesions in rats in the very same watermaze appa-
ratus, in the very same testing room, with the very same spatial
cues as used here in the current MAM E17 study (e.g.
Bannerman et al. 1999). Thus, we are confident that our
watermaze paradigm is a truly hippocampus-dependent test
of spatial memory.
Fig. 4 MAM E17 exposure
impaired spatial novelty
preference in the Y-maze. Results
are presented as the mean±SEM
of the number of arm entries made
(a) and time spent (b) in both the
novel (blank) and familiar
(striped) arms during the test
phase, for both MAM E17 (grey,
n=14) and saline controls (white,
n=12). Difference (c) and ratio
(d) between the time spent in the
novel versus familiar arm are also
presented, as well as the time
spent in the to-be familiar arm
during the exposure phase (e).
*P<0.05 vs. the saline-treated
group
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In addition, we have also shown that the spatial reference
memory deficit extends to the non-aversive, appetitively mo-
tivated Y-maze task. MAM E17 rats also exhibited a short-
term spatial memory deficit on the Y-maze novelty preference
task. These findings therefore demonstrate MAM E17-
induced deficits in several hippocampus-dependent memory
tasks. However, it is also worth noting that, although signifi-
cantly impaired in both the watermaze and appetitive Y-maze
tasks, the MAM E17 rats are capable of demonstrating spatial
learning in both paradigms. For example, after 32 watermaze
training trials, the MAM E17 animals were showing a signif-
icant preference for the target quadrant during probe test 2
(spending almost 40 % of time in the correct quadrant), albeit
they were still impaired relative to controls. Moreover, the
MAM E17 deficit in the appetitive Y-maze task is transient,
with the two groups being indistinguishable after day 3 of
training. Therefore, MAM treatment does not completely pre-
vent hippocampus-dependent spatial learning. This is maybe
not surprising given the more subtle effect of the MAM ma-
nipulation on hippocampal pathology and/or physiology,
compared to a hippocampal lesion for example. Importantly,
we found only minimal effects on non-spatial control tasks in
the MAME17 rats. Thus, the spatial memory deficits reported
here are unlikely to reflect gross disturbances in sensorimotor
or motivational processes which are necessary for task
performance.
These MAM E17-induced deficits in spatial information
processing are potentially in line with previous demonstra-
tions of altered hippocampal pathology in these animals
(Moore et al. 2006; Lodge and Grace. 2009; Hradetzky et al.
2012; Sanderson et al. 2012). However, it is also important to
point out that we would not rule out the possibility of an extra-
hippocampal contribution to these spatial deficits, given the
likely role that other brain areas, including cortex, play in
spatial memory performance (see Bannerman et al. 2014 for
discussion). Furthermore, it is also not clear which particular
aspect (or aspects) of hippocampal physiology have been
disrupted in order to produce these impairments. For example,
recent proteomic and metabolic analyses of hippocampal
slices from MAM E17 rats, identified changes in AMPA-R
subunit expression and phosphorylation, suggesting synaptic
transmission and plasticity may be altered in MAM rats,
which could explain impairments in long-term spatial memory
in these animals (Hradetzky et al. 2012). MAM E17-exposed
animals also have significantly altered NMDA-R protein
levels and function in hippocampus, both during juvenile
Fig. 5 MAM E17 exposure
reduced anxiety levels in the
elevated plus maze. Two separate
cohorts of animals were assessed:
experimentally naïve (MAM:
grey, n=16; saline: white, n=13)
and trained animals (MAM grey,
n=14; saline white, n=12).
Results are presented as the mean
±SEM of the time spent (a) and
number of arm entries made (b) in
the open arms of the maze. The
mean±SEM of the ratios of time
spent (c) and arm entries (d) in
open arms are also expressed.
*P<0.05 vs. the saline-treated
group. ##P<0.01; ###P<0.001 vs.
the experimentally naïve cohort
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and adolescent stages of development. These changes have
been linked with learning and memory deficits in the Morris
Watermaze (Snyder et al. 2013), although the contribution that
hippocampal NMDARs make, if any, to spatial memory per-
formance in the watermaze in adulthood is still a matter of
debate (see Bannerman et al. 2014 for discussion).
Moreover, both the dorsal and ventral hippocampal subre-
gions in adult MAM E17 rats display increased excitability/
activity, reduced synaptic transmission and altered
depotentiation (Lodge and Grace. 2007; Sanderson et al.
2012). Some or all of these physiological phenotypes could
contribute to the behavioural phenotype that we have
observed.
It is also of note that MAME17 rats are more susceptible to
stress-induced alterations in synaptic plasticity and behaviour
(Goto and Grace. 2006; Sanderson et al. 2012; Du and Grace.
2013; Zimmerman et al. 2013). Along these lines, it is inter-
esting to note that the MAME17-induced spatial deficits were
far greater in the Morris watermaze task compared to the ap-
petitive Y-maze task. We acknowledge (i) that it is very diffi-
cult to compare across different measures of performance in
different tasks, (ii) that there are various other important pro-
cedural differences between these two tasks which could ex-
plain differences in the magnitude of these effects and (iii) that
they likely depend on different psychological processes to
some extent (Bannerman et al. 2012). Nevertheless, these re-
sults are consistent with the possibility that the MAM E17
deficits might be, at least partly, dependent upon the levels
of stress and/or arousal that the animals are subjected to during
task performance.
MAM E17 reduced anxiety levels
Alongside its role in spatial information processing, the hip-
pocampus has long been associated with aspects of emotion-
ality and, in particular, with anxiety (Gray 1982; Gray and
McNaughton. 2000). Anxiety is associated with conflict or
uncertainty, and has evolved to prevent the subject from going
into potentially dangerous situations. Rodent tests of anxiety,
such as the elevated plus maze, are based on an approach
versus avoidance conflict with the animal being required to
choose whether to explore the open, exposed arms of the maze
(approach), or to stay in the safe, enclosed sections (avoid-
ance). In the present study, MAM E17 rats spent a greater
amount of time and made more entries into the open arms of
the elevated plus maze compared to saline controls, consistent
with reduced anxiety in these animals, and highlighting their
increased tendency to approach and explore an uncertain (and
hence potentially dangerous) environment. This subtle but
significant reduction in anxiety is in direct contrast with recent
studies suggesting elevated anxiety levels and abnormal stress
responsivity in adolescent MAM E17 rats. Indeed, Du and
Grace (2013) found increased (rather than decreased) anxiety
on the elevated plus maze in MAM E17 rats when tested in
adolescence. Thus, the anxiety phenotype in MAM rats may
be dependent on the age of the animals, which is potentially
consistent with the hypothesis that these animals are more
sensitive to the effects of stress in their youth. For example,
Zimmerman et al. (2013) have shown an increased stress re-
sponse inMAME17 animals compared to controls in juvenile
animals, but found that this effect was not present in older
animals. Further studies are required to understand better
how different aspects of emotionality are affected at different
developmental stages in the MAMmodel, and how these phe-
notypes interact with the stress response.
We also cannot rule out the possibility that deficits in spa-
tial memory abilities, and their resulting effects on spatial
exploration, could influence the behaviour of the MAM ani-
mals on the elevated plus maze (both in this study and also
elsewhere). The time spent in the open and closed arms of the
elevated plus maze will, in part, reflect the relative ability of
the different sections of the maze to induce exploration. This
will, of course, depend on the salience of the different sec-
tions, the animals’ starting location, and the rate of habituation
in the different experimental groups. The latter may of course
depend on the spatial memory abilities of the rats. Thus, there
could be a complex set of interactions between different psy-
chological processes during elevated plus maze performance,
which might also vary from one laboratory to the next, de-
pending the dimensions and character of the maze, the extra-
maze cues available, and the precise testing protocol adopted
(see also Fitzgerald et al. 2010 for discussion). Against this, it
is also worth pointing out that rats with dorsal hippocampal
lesions display very pronounced spatial memory impairments
but can behave normally on such approach/avoidance conflict
tests (Kjelstrup et al. 2002; McHugh et al. 2004; but see also
Bannerman et al. 2002).
Conversely, we cannot completely rule out the possibility
that the spatial memory impairments may in some way reflect
the reduced anxiety levels in theMAME17 rats. However, the
nature and direction of any interaction between anxiety levels
and spatial memory performance in the watermaze is difficult
to predict. On the one hand, one might argue that reduced
anxiety levels might lead to less motivation to escape from
the water but, equally, one might argue that reduced anxiety
might result in a reduced stress response and it is well
established that high levels of stress can disrupt
hippocampus-dependent learning (Sandi and Pinelo-Nava.
2007). Notably, rats treated with an anxiolytic dose of the
benzodiazepine chlordiazepoxide are impaired in the
watermaze (McNaughton and Morris. 1987). In contrast, rats
with ventral hippocampal lesions, which also display reduced
anxiety (e.g. Bannerman et al. 2002, 2004; Kjelstrup et al.
2002; McHugh et al. 2004), are generally unaffected in the
Morris watermaze task (see Moser et al. 1995; Bannerman
et al. 1999, 2002; Kjelstrup et al. 2002). In fact, in one study,
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ventral hippocampal lesioned animals actually performed bet-
ter than controls in a spatial reference memory version of the
Morris watermaze task, similar to that used in the present
study (Richmond et al. 1999).
Disentangling mnemonic effects from emotionality effects
in the present watermaze study may be particularly difficult,
given the subtle but significant deficit in theMAME17 rats on
the non-spatial, visible platform control task. In contrast, the
spatial deficit in the appetitive Y-maze task was accompanied
by normal performance on the appetitive, non-spatial visual
discrimination maze task. These tasks are fairly well matched
for sensorimotor and motivational demands, and there is no
reason to think that they will differ in the levels of anxiety that
they might generate. Although, it is important to point out that
the order of testing was not counterbalanced which could be
an important factor. Thus, on the basis of these data, one might
conclude that there is a genuine spatial memory deficit in these
animals which cannot be attributed to reduced levels of
anxiety.
Of course the fact that MAM E17 rats display reduced
anxiety on the elevated plus maze is not obviously consistent
with what is seen in schizophrenic patients, with increased
anxiety often acting as a trigger for psychotic episodes
(Lysaker and Salyers. 2007). Moreover, anxiety disorders,
featuring increased anxiety, show a high comorbidity with
schizophrenia (Achim et al. 2011). Therefore, it remains im-
portant to investigate further how apparently similar morpho-
logical changes may trigger different behavioural/emotional
phenotypes in MAM E17 rats compared to schizophrenic
patients.
The present findings are however more generally consis-
tent with a ventral hippocampal dysfunction in these animals.
MAM E17 rats display anatomical and neurophysiological
changes in the ventral part of the hippocampus (Sanderson
et al. 2012). Increasing evidence suggests that the spatial
memory and anxiety functions of the hippocampus are pref-
erentially associated with its dorsal and ventral subregions,
respectively (Moser et al. 1995; Bannerman et al. 2004,
2014; Fanselow and Dong. 2010). Ventral hippocampal le-
sions have been found to reduce anxiety on a number of
ethologically based tests including the elevated plus maze test
(Bannerman et al. 2002, 2003; Kjelstrup et al. 2002).
However, determining which aspect or aspects of ventral hip-
pocampal dysfunction are important, and how they determine
the directionality of any effect on anxiety (anxiogenic versus
anxiolytic) requires further study.
Conclusions—MAM E17 as a model of hippocampal
dysfunction in schizophrenia
Offspring of rats dosed with MAM at E17 showed robust
deficits in a wide range of hippocampus-dependent behaviour-
al assays, including several spatial memory tasks and the
elevated plus maze test of anxiety. While these behavioural
phenotypes likely reflect, at least in part, the well-documented
changes in hippocampal physiology reported previously in
these animals, their relationship to the symptoms seen in
schizophrenic patients remains unclear, particularly in terms
of any emotionality phenotypes. Further studies are required
to understand better these changes in emotionality induced by
pre-natal MAM treatment, and to determine whether differen-
tial responses to stress and/or arousal could also impact on the
cognitive phenotypes observed.
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